Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Revenue (2023 - 2025)

Zenas BioPharma (ZBIO) has 2 years of Revenue data on record, last reported at $10.0 million in Q1 2025.

  • For Q1 2025, Revenue changed N/A year-over-year to $10.0 million; the TTM value through Sep 2025 reached $15.0 million, changed N/A, while the annual FY2024 figure was $5.0 million, 90.0% down from the prior year.
  • Revenue reached $10.0 million in Q1 2025 per ZBIO's latest filing, up from $5.0 million in the prior quarter.
  • Across five years, Revenue topped out at $10.0 million in Q1 2025 and bottomed at $5.0 million in Q4 2024.